Eisai: Dayvigo (Lemborexant) Approved for Treatment of Insomnia in Japan
- Written by ACN Newswire - Press Releases
DAYVIGO is a dual orexin receptor antagonist that inhibits orexin
Read more //?#
.
Bunji dog treats to hit Ritchies shelves
Cooee Native Superfoods’ Bunji range of dog kibble and treats is rolling out across Ritchies Supermarkets now, with stock already on shelves in se...
Pre-Budget Expectations
“Australian corporates and SMBs are under pressure. Competition from global players is intensifying, margins are under strain, and technology adop...
“Time is running out to get Payday ready,” Brighter Super urges
Superannuation fund Brighter Super is encouraging business owners to prepare now for Payday Super, ahead of the new laws taking effect from 1 July...
PayNuts Unveils Expanded Integrated Solutions and Refreshed Brand to Support Australian SMEs
PayNuts, one of Australia’s fastest-growing payment service providers, has unveiled a refreshed brand identity and an expanded suite of integrated b...
BizCover Brings Australia’s First AI-Based Insurance Quotes to ChatGPT
Australian small business owners can now receive and compare business insurance quotes directly inside ChatGPT, in a move that signals a major shi...
VistaPrint Research Reveals Australian Small Businesses Face a Succession Cliff
With only 16% of retiring small businesses having a succession plan, tens of thousands risk closure as one in three owners nears retirement. Ne...